Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
November 22, Wednesday 2017 9:11 AM       

       HEADLINES: Purchasing laptop under IT@school: Laptop price reduced by Rs 455                                              One arrested in connection with attack on Mayor                                              There was no pressure: Justice P S Antony                                              Clashes in Munnar hartal, CPI not participating                                              ‘Honey trap’ case against A K Saseendran: Commission submits report                                              ‘Padmavati’ row: Kamal wants Deepika’s head 'saved'                                              Indian Army breaks world record with 58 men on single bike                                              IFFI 2017: Sridevi inaugurates Indian Panorama                                              Finally, Robert Mugabe resigns                                              Kohli climbs to fifth spot in Test rankings                                              Sindhu leads India's challenge at Hong Kong Open                                              India vs SL: Bhuvi, Dhawan released from team                                              Kaumudi Facebook
       SCI&TECH Next Article: Aspirin a day may keep liver cancer away  
       Suicide molecules may help combat cancer: Study
 
         Posted on :23:38:54 Oct 22, 2017
   
A A
       Last edited on:23:38:54 Oct 22, 2017
         Tags: Suicide molecules may help combat cancer: Stu
 

WASHINGTON DC: A team of researchers has recently found a "suicide molecule" that forces tumours to self-destruct and trigger a fail-safe mechanism that may protect us from cancer.

Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a study, the first to identify molecules to trigger a fail-safe mechanism that may protect us from cancer.

According to researchers from Northwestern University, the mechanism -- RNA suicide molecules -- can potentially be developed into a novel form of cancer therapy.

Cancer cells treated with the RNA molecules never become resistant to them because they simultaneously eliminate multiple genes that cancer cells need for survival.

"It's like committing suicide by stabbing yourself, shooting yourself and jumping off a building all at the same time," said lead study author Marcus Peter.

The team discovered sequences in the human genome that when converted into small double-stranded RNA molecules trigger what they believe to be an ancient kill switch in cells to prevent cancer.

He has been searching for the phantom molecules with this activity for eight years.

This study describes the discovery of the assassin molecules present in multiple human genes and their powerful effect on cancer in mice.

Thus began his search for natural molecules coded in the genome that kill cancer.

Peter stated that the kill mechanism would only be active in a single cell the moment it becomes cancerous. It was a needle in a haystack.

But he found them by testing a class of small RNAs, called small interfering (si)RNAs, scientists use to suppress gene activity.

siRNAs are designed by taking short sequences of the gene to be targeted and converting them into double- stranded RNA. These siRNAs when introduced into cells suppress the expression of the gene they are derived from.

Peter found that a large number of these small RNAs derived from certain genes did not, as expected, only suppress the gene they were designed against. They also killed all cancer cells.

His team discovered these special sequences are distributed throughout the human genome, embedded in multiple genes as shown in the study in Cell Cycle.

To test this in a treatment situation, Peter collaborated with Dr Shad Thaxton, associate professor of urology at Feinberg, to deliver the assassin molecules via nanoparticles to mice bearing human ovarian cancer.

In the treated mice, the treatment strongly reduced the tumor growth with no toxicity to the mice, reports the study in Oncotarget.

Importantly, the tumors did not develop resistance to this form of cancer treatment.

"The problem is cancer cells are so diverse that even though the drugs, designed to target single cancer driving genes, often initially are effective, they eventually stop working and patients succumb to the disease," Peter stated.

Most of the advanced solid cancers such as brain, lung, pancreatic or ovarian cancer have not seen an improvement in survival, Peter said.

The research appears in eLife journal.

A A
       SCI&TECH
Next Article: Aspirin a day may keep liver cancer away
 
 
SCI&TECH HEADLINES
How breastmilk protects babies from food allergy decoded  
Stars among the oldest in our galaxy discovered  
Apple delays release of smart speaker - HomePod  
Owning a dog may add years to your life  
'Textisms' actually add meaning to written words  
Sugar may heal wounds, says study  
Heart-stopping sex? It's rare  
Over 1.3 lakh Indians 'book ticket' to Mars  
China all set to make first contact with aliens  
Greenland Ice sheet could be losing mass, says study  
'Flying taxis' could be a thing by 2020  
When art comes to the rescue of depressed patients  
Here's a mechanism that can help you get rid of bad memories  
2017 ozone hole smallest since 1988: NASA  
Marijuana can dull the brain in some HIV patients  
We use lesser brainpower than thought  
You can soon delete 'sent messages' on WhatsApp  
There is a connection between nose and emotions  
75% of pet reptiles die within a year: Study  
Gamma rays will reach beyond limits of light: Researchers  
Suicide molecules may help combat cancer: Study  
Aspirin a day may keep liver cancer away  
Clearing the myths about osteoporosis  
Stress as unhealthy as junk food  
Planet Nine does exist in solar system: NASA  
 
Do you think media was banned at CM's office on Tuesday?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy